Jeffrey Treiber

1 clinical trials · Sponsor

Record	Firm	Date
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies (NCT06466798)	Jeffrey Treiber	2024-07-15

Every clearance here is in the API, with alerts when new ones post.